This Portuguese BRCA2 founder mutation is present in ~30% of all Portuguese families with hereditary breast and ovarian cancer, representing 55% of all BRCA2 germinal mutation carriers in Portugal [31]. This evidence concerns the gene BRCA2 and ovarian carcinoma.